Through these mechanisms, GLP-1 analogs not only improve blood sugar control but also contribute to weight loss, making them highly advantageous for patients with type 2 diabetes mellitus and obesity.1 Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.